The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany
Background: Real-word evidence from diverse data sources is increasingly important in terms of generating rapid insights to effectively manage patient populations, especially during major public health disruptions such as the ongoing COVID-19 pandemic. Patients with chronic and inflammatory diseases...
Main Authors: | Jonathan Orschiedt, Elizabeth Jacyshyn-Owen, Maria Kahn, Sven Jansen, Natalie Joschko, Markus Eberl, Sebastian Schneeweiss, Benjamin Friedrich, Tjalf Ziemssen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222015189 |
Similar Items
-
The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany
by: Maria Kahn, et al.
Published: (2023-09-01) -
Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany
by: Preetha Balakrishnan, et al.
Published: (2022-07-01) -
Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app
by: Steffeni Mountford, et al.
Published: (2023-05-01) -
Impact of Illegible Prescriptions on Dispensing Practice: A Pilot Study of South African Pharmacy Personnel
by: Tasneem Modi, et al.
Published: (2022-10-01) -
Barriers and facilitators to implementing simulation into pharmacy programs globally
by: Harjit K. Singh, et al.
Published: (2023-02-01)